PNBCX
Price
$29.47
Change
-$0.11 (-0.37%)
Updated
Sep 5 closing price
Net Assets
283.7M
VVIAX
Price
$71.19
Change
-$0.24 (-0.34%)
Updated
Sep 5 closing price
Net Assets
202.84B
Interact to see
Advertisement

PNBCX vs VVIAX

Header iconPNBCX vs VVIAX Comparison
Open Charts PNBCX vs VVIAXBanner chart's image
Virtus NFJ Large-Cap Value C
Price$29.47
Change-$0.11 (-0.37%)
VolumeN/A
Net Assets283.7M
Vanguard Value Index Adm
Price$71.19
Change-$0.24 (-0.34%)
VolumeN/A
Net Assets202.84B
PNBCX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PNBCX vs. VVIAX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PNBCX is a StrongBuy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 203B vs. PNBCX (284M). VVIAX pays higher dividends than PNBCX: VVIAX (2.10) vs PNBCX (0.52). PNBCX was incepted earlier than VVIAX: PNBCX (23 years) vs VVIAX (25 years). PNBCX (1.76) is less costly to investors than VVIAX (0.05). PNBCX is a more actively managed with annual turnover of: 56.00 vs. VVIAX (9.00). PNBCX has a lower initial minimum investment than VVIAX: PNBCX (2500) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 7.74 vs. PNBCX (2.32). VVIAX return over 5 years is better than : 70.16 vs. PNBCX (13.63).
PNBCXVVIAXPNBCX / VVIAX
Total Expense Ratio1.760.053,520%
Annual Report Gross Expense Ratio1.760.053,520%
Fund Existence23 years25 years-
Gain YTD5.3737.85068%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets284M203B0%
Annual Yield % from dividends0.522.1025%
Returns for 1 year2.327.7430%
Returns for 3 years1.8536.615%
Returns for 5 years13.6370.1619%
Returns for 10 years51.79131.6139%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMCX7.560.20
+2.72%
AMC Networks
INMB1.950.03
+1.56%
INmune Bio
ACGLN18.080.19
+1.06%
Arch Capital Group Ltd
ARDX6.52-0.05
-0.76%
Ardelyx
HQY91.48-6.22
-6.37%
HealthEquity